Introduction
Endocrine disruptors (EDs) are of tectonic significance to sustainability. EDs typically display non-monotonic dose- 15 response behavior and at low doses are often able to impair cells and animals by altering the hormonal control of development. 1 Certain active pharmaceutical ingredients, pesticides, flame retardants, polymer consituents including monomers and additives, and other everyday chemicals are now known to be 20 EDs. Three strategies are apparent for coping with EDs: regulate, replace, remediate. The latter two fall into the province of green chemistry.
Recently, the ability of chemists to design against EDs took a major step forward upon the publication in this journal of the 25 Tiered Protocol for Endocrine Disruption (TiPED). 2 The five-tier TAML activators (Fig. 1) are emblematic of developing green approaches to water treatment. These miniaturized peroxidase replicas are known to catalyse peroxide processes under mild conditions giving the rapid, oxidative decomposition of water-55 borne contaminants of concern among which are many persistent EDs. Examples include, inter alia, pentachlorophenol, 2,4,6-trichlorophenol, thiophosphate pesticides, the drug Sertraline, and the estrogens 17α and β-estradiol, estrone, and EE2. [4] [5] [6] [7] Given the goal of green water treatment, we consider it 60 essential that TAML activators, their degradation products, and all other aspects of the catalysed processes should be examined for and made free of endocrine disruption by design. To this end, initial work on three TAML activators in collaboration with Bruce Blumberg has yielded negative estrogen, androgen, and thyroid receptor activation in cellular assays (TiPED Tier 2). In this study, we extend the search for potential low dose toxicity endpoints associated just with exposures to TAML catalysts (and not yet the decomposition products or process solutions) via in vivo zebrafish assays (TiPED Tier 4). The zebrafish is an 70 emerging model for the assessment of developmental toxicity and human health. [8] [9] [10] Utilizing this model for Tier 4 tests yields expanded opportunities for exploring a diversity of toxicity endpoints which may or may not result from ED processes.
Results and Discussion

75
The embryonic zebrafish model was used to assess the developmental toxicity of seven TAML activators (1a-c, 2a-d).
Dechorionated embryos were statically exposed to seven concentrations of each activator (0 -250 µM) and evaluated for developmental malformations at 24 and 120 hours post 80 fertilization (hpf). Only embryos that survived were accounted for in malformation statistics. At 24 hpf, embryos were evaluated for mortality (MO24), developmental progression (DP24), spontaneous movement (SM24), and notochord distortion (NC24). In addition, embryos were screened at 120 hpf for 18 endpoints. Individual embryos 10 were scored for mortality (MORT), then euthanized and evaluated for abnormal morphology. The embryos that survived were evaluated for fifteen morphological malformations: yolk sac edema (YSE), bent body axis (AXIS), eye (EYE), snout (SNOU), Most of the observed mortality resulted from higher concentration exposure and occurred within the first 24 hpf. Only two activators induced prominent (>30% incidence) embryo (Fig. 3a) and did not result from exposure to any of the other five activators. Li[1b] also induced prominent malformations of the body axis, snout and jaw, as well 25 as pericardial edema, but only at 250 µM. No malformation data could be gathered for Li[2b] at 50 and 250 µM (100% mortality). However at 10 µM, this activator caused 100% incidence of malformations of the eye, snout, and jaw as well as pericardial edema in addition to a 75% incidence of yolk sac edema and 30 brain malformations. In addition to impacts on the body axis discussed above, Li[2c] induced prominent developmental malformations of the jaw at 50 and 250 µM and of the body axis, jaw and trunk at 50 µM. Touch response malformations resulted only from exposure to Li[2b] at 10 µM. 35 LC 50 values (the concentrations of compounds causing mortality in 50% of the sample) and/or EC 50 values (the concentrations of compounds eliciting adverse effects including mortality and any malformations in 50% of the sample) were computed ( 32, and 4.5 µM. It is noteworthy that both EC 50 and LC 50 values for these four activators are greater than those concentrations typically employed in TAML processes (<2 µM). 
Nitro-and chloro-aromatics
Nitro-and chloro-aromatics are often associated with toxicity that is also structure dependent. Nitro groups appear to induce minimal toxicity compared with chloro groups in the studied 55 series and the observed toxicities are markedly structure dependent. We consider that this emphasizes the importance of the TiPED approach for unraveling subtle structure-activity toxicity relationships. Indeed, the two aromatic chlorine substituents make 1b significantly more toxic than the singly 60 nitrated 1c. The most extensively chlorinated catalyst 2b is clearly the most toxic of the entire tested set with an LC 50 of 26.7 µM and an EC 50 of 4.5 µM, ~20 fold more toxic than Li[2d] . This study suggests a tentative toxicity ordering for the aromatic substituents of Cl > CN > NO 2 . However, more structures with 65 these substituents would need to be analysed to assess whether this represents general functional group effects or specific molecular manifestations of toxicity for TAML activators.
Conclusions
The results of this work clearly show that TAML activators are 70 not toxic to zebrafish at concentrations ≤2 µM. Since water treatment is likely to employ TAML activator concentrations at the lower end of the 0.01 -1 µM range, these results are encouraging. As Fig. 2a illustrates, catalyst structural features determine higher dose adverse effects making it clear that an 75 interplay between TAML catalyst design and zebrafish toxicity feedback has potential for guiding the green design of these singular peroxidase mimics. This work highlights the vital need for interdisciplinary collaborations between chemists and toxicologists and emphasizes the need for the TiPED analytical 80 design guide. By both utilizing an in vivo assessment platform and being able to precisely control the structural features of TAML activators, we are developing a collaborative platform for informing the design of homogenous green oxidation catalysts.
Experimental
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General procedure for sample preparation
A sample of each TAML activator (10 mg) was dissolved in ultrapure water (1 mL) and diluted with the appropriate volume of embryo medium (EM) to give a 5 mM working solution. Standard EM consisted of 15 mM NaCl, 0. 
